Back

Pathways and biomarkers of selenium deficiency in heart failure patients

18 May 2025 (11:57 - 12:06)
Organised by: Logo
Congress Presentation Part of: From genetic signatures to clinical implications Biomarkers HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor John Molvin

Department of Cardiology, Malmoe (Sweden)

6 More presentations in this session

Presentation thumbnail
Pathophysiological pathways related to elevated soluble ST2 concentrations and survival in patients with heart failure
Mr T. Bergwerff (Groningen, NL)
Abstract Slides Video
Presentation thumbnail
Genetic architecture and proteomic landscape of acceleration and deceleration capacity as surrogates of cardiac sympathetic and parasympathetic function in heart failure
Ms S. Zeid (Mainz, DE)
Abstract Slides Video
Presentation thumbnail
Circulating mitochondrial DNA signature across the heart failure spectrum
Doctor N. Pugliese (Pisa, IT)
Abstract Slides Video
Presentation thumbnail
Longitudinal assessment of spot urinary sodium as predictor of clinical outcomes in chronic heart failure
Doctor M. Lorenzo Hernandez (Valencia, ES)
Abstract Slides Video
Presentation thumbnail
Peripheral blood cytokine levels do not correlate with myocardial presence of inflammatory cells or MACE in cardiac transthyretin and immunoglobulin light chain amyloidosis
Mr N. Musigk (Berlin, DE)
Abstract Slides Video

Access the full session

Session thumbnail
From genetic signatures to clinical implications
Video

The Event

Event poster

Heart Failure 2025

18 May 2025 11:57 CET
You may be interested in
thumbnail
Congress Presentation
Selenoprotein-P deficiency is associated with higher risk of incident heart failure
28 August 2022
thumbnail
Congress Presentation
Micronutrient deficiencies in heart failure and relationship with exocrine pancreatic insufficiency
18 May 2025
thumbnail
Congress Presentation
Biomarker profiles for heart failure phenotyping
19 May 2025
thumbnail
Congress Presentation
Selenium supplementation in heart failure: design and rationale of the SIRI-HF Trial
19 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources